'%2F%3E%3Cpath%20d%3D'M6.5%2025%2016%207%2025.5%2025'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.8'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'16'%20cy%3D'19'%20r%3D'3.2'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
BDH INDUSTRIES LTD.
BDH (BSE 524828) · ISIN INE278D01018 · Pharmaceuticals · Est. 1990 · listed 1995 · website
Not on any surveillance list
Quarterly results
No quarterly results stored for this company yet.
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹77.01 cr | ₹2.02 cr | ₹99.09 cr |
| 30 Sep 2025 standalone | ₹70.62 cr | ₹0.03 cr | ₹88.93 cr |
| 31 Mar 2025 standalone | ₹68.76 cr | ₹0.98 cr | ₹86.94 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 49.70% | 0.28% | 0.00% | 50.30% |
Latest filings
- Kindly find the enclosed herewith the voting results of the 36th Annual General Meeting alongwith consolidated Scrutinizers Report. 14 August 2026 · BSE
- The proceedings of the 36th Annual General Meeting of the Company held on 14th August 2026 through VC / OVAM are enclosed herewith for reference. 14 August 2026 · BSE
- Kindly note that the Board of Directors of the Company have approved the Standalone Unaudited Financial Results for the quarter ended on 30th June 2026 of the financial year 2026-27 as .... 14 August 2026 · BSE
- Kindly note that the Board of Directors of the Company have approved the Standalone Unaudited Financial Results for the quarter ended on 30th June 2026 of the financial year 2026-27 as .... 14 August 2026 · BSE
- Annual Report FY2025-26 (New) 22 July 2026 · BSE
Other companies in Pharmaceuticals
- Sun Pharmaceutical Industries Limited
- Lupin Limited
- Cipla Limited
- Dr. Reddy's Laboratories Limited
- Torrent Pharmaceuticals Limited
- Zydus Lifesciences Limited
- Mankind Pharma Limited
- Aurobindo Pharma Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.